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Saccadic distractibility is elevated in schizophrenia
patients, but not in their unaﬀected relatives
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REBECCA WALWYN 2, COLM D. MCDONALD 1 AND ROBIN M. MURRAY 1
1 Division of Psychological Medicine, 2 Department of Biostatistics and Computing, Institute of Psychiatry,
London, UK
ABSTRACT
Background. Saccadic distractibility, as measured by the antisaccade task, has attracted attention
as a putative endophenotypic marker for schizophrenia. Some studies have suggested that this
measure is elevated in the unaﬀected relatives of schizophrenia patients. However, recent studies
have called this into question and the topic remains controversial.
Method. Saccadic distractibility was measured in 53 patients with DSM-IV schizophrenia, 80
unaﬀected ﬁrst-degree relatives and 41 unaﬀected controls.
Results. Schizophrenia patients performed worse than relatives and controls combined (p<
0.00001), but relatives did not diﬀer signiﬁcantly from controls. Performance in multiply aﬀected
families was no worse than that in singly aﬀected families. Relatives with a high presumed genetic
risk for schizophrenia performed no worse than other relatives. The performance of the patients
did not predict that of their relatives.
Conclusions. These results demonstrate that saccadic distractibility is strongly associated with
disease status but not with genetic loading for schizophrenia. We conclude that saccadic distract-
ibility is unlikely to be useful as an endophenotypic marker in schizophrenia.
INTRODUCTION
Family, twin and adoption studies have indi-
cated that operationally deﬁned schizophrenia
has a heritability of over 0.8 (Cardno et al.
1999). However, the non-Mendelian segregation
within families and the disparate linkage ﬁnd-
ings suggest that schizophrenia is a complex,
polygenic disorder (Gottesman & Shields, 1982).
Genetic transmission in schizophrenia is likely
to be further complicated by epistasis (Wade,
2001) (non-additive interactions between genes),
pleiotropy (Hodgkin, 1998) (a single gene deter-
mining two or more characteristics), incomplete
penetrance (Levinson et al. 1996), interactions
with environmental factors (Van Os & Sham,
2002), and the probable aetiological hetero-
geneity of the clinically deﬁned disorder
(Cardno & Gottesman, 2000).
One approach to overcoming these problems
is the use of intermediate phenotypes, or bio-
logical markers. These are anatomical, physio-
logical or biochemical variables that segregate
with genetic risk for the disorder, and which
are assumed to have a simpler genetic architec-
ture than the disorder itself (Weinberger, 2002),
with a more proximal relationship to the
underlying genes. It is hoped that the use of
biological markers will identify more homo-
geneous groups of subjects within the broader
clinically deﬁned phenotype, and thus lead to
improved success in the search for susceptibility
genes.
The necessary criteria for a biological marker
were set out by Wickham & Murray (1997).
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The most important criterion, and the one that
has received the most research attention, is an
increased prevalence of the marker in the
unaﬀected relatives of aﬀected subjects. Several
putative biological markers have been studied,
including structural brain changes (McDonald
et al. 2004), endogenous event-related poten-
tials (Bramon et al. 2004) and performance on
a variety of neuropsychological tasks (Toulo-
poulou et al. 2003).
The study of eye-movement abnormalities as
potential biological markers for schizophrenia
dates back to the 1970s (Holzman et al. 1974).
Initially research focused on abnormalities of
smooth pursuit eye movements, but recently,
the study of saccadic eye movements has
attracted attention, particularly the antisaccade
task.
The antisaccade task
The standard antisaccade task (Hallett, 1978)
begins with the subject ﬁxating on a central
illuminated target. The target then moves
rapidly to a peripheral location, and the subject
is required to inhibit his/her reﬂexive saccade
(in pursuit of the target) and to generate, in-
stead, a saccade in the opposite direction, which
is termed an antisaccade. A saccadic distract-
ibility error is recorded if a subject fails to
inhibit the reﬂexive saccade in the direction
of the target. Saccadic distractibility is usually
expressed as the percentage of trials in which the
initial eye movement was towards the stimulus.
Variations of the task include a gap or overlap
(McDowell & Clementz, 1997) between the oﬀ-
set of the central stimulus and the onset of the
peripheral stimulus.
Every published study to date examining
the antisaccade task in schizophrenia and its
variants has demonstrated that schizophrenia
patients perform more poorly than control
subjects in suppressing reﬂexive saccades,
regardless of variations in the paradigm (Levy
et al. 2004). By contrast, studies that have
examined the ability of schizophrenia patients
to perform simple reﬂexive saccades have found
that their performance is within the normal
range (Crawford et al. 1995a).
Several studies have examined the prevalence
of saccadic distractibility errors in unaﬀected
relatives of patients with schizophrenia, in-
cluding one study by our research group
(Crawford et al. 1998). Some studies have
shown evidence of elevated rates of saccadic
distractibility errors in well relatives compared
to control populations (Curtis et al. 2001;
Karoumi et al. 2001) but others have either
found non-signiﬁcant diﬀerences, or have not
presented a statistical test comparing well
relatives with controls (Thaker et al. 1996,
2000; Katsanis et al. 1997; Crawford et al.
1998; Brownstein et al. 2003). Two recent meta-
analyses have investigated the presence of
abnormalities in the unaﬀected relatives of
schizophrenia patients. Calkins and colleagues
(2004) demonstrated that when all studies are
combined, relatives perform worse than con-
trols. However, Levy et al. (2004) showed that
studies which applied more stringent exclusion
criteria to controls than to relatives reported
large eﬀect sizes, whereas those with symmetri-
cal criteria showed small and non-signiﬁcant
diﬀerences.
As well as being over-expressed in the well
relatives of patients, biological markers should
correlate with the likelihood of carrying suscep-
tibility genes, both between and within families.
Thus, members of multiply aﬀected families are
hypothesized to have poorer eye tracking than
members of singly aﬀected families (Lewis et al.
1987). This hypothesis has previously been
tested in a small study by Ross et al. (1998), with
negative results.
A further prediction is that within multiply
aﬀected families, relatives who appear to be
‘carriers ’ of the genetic risk for schizophrenia
have worse performance than other members of
multiply aﬀected families. An example of such
a ‘presumed obligate carrier ’ would be a man
whose daughter and brother both had schizo-
phrenia, but who was not aﬀected himself. Ross
et al. (1998) found that these ‘presumed obligate
carriers ’ had worse performance than other
well relatives.
To summarize, previous research has demon-
strated that schizophrenia patients perform
worse than control subjects on the antisaccade
task, but the crucial question as to whether this
trait is related to genetic risk for schizophrenia,
thus warranting further investigation as a puta-
tive biological marker for schizophrenia, re-
mains controversial (Brownstein et al. 2003).
We therefore examined antisaccades in both
schizophrenia patients and their relatives from
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both singly and multiply aﬀected families. Our
hypotheses were as follows:
(1) Schizophrenia patients will perform
worse than their unaﬀected relatives and normal
controls.
(2) Unaﬀected ﬁrst-degree relatives of pa-
tients will perform worse than normal controls.
(3) Patients from multiply aﬀected families
will perform worse than those from singly
aﬀected families.
(4) Relatives from multiply aﬀected families
will perform worse than those from singly
aﬀected families.
(5) Among the relatives from multiply aﬀec-
ted families, presumed obligate carriers will
perform worse than the remainder.
(6) Relatives of patients who perform poorly
will have worse performance than relatives
of patients who perform well.
METHOD
The study was conducted as part of the
Maudsley Family Study (McDonald et al. 2004),
a larger investigation of biological markers in
schizophrenia patients and their relatives. There
is no overlap between the data presented here
and the data previously reported by Crawford
et al. (1998).
Subjects
All subjects were Caucasians, aged 16–69 years,
whose ﬁrst language was English. Exclusion
criteria were substance or alcohol dependence in
the previous year, or a lifetime history of sig-
niﬁcant head injury or organic brain disease.
Subjects gave informed written consent for their
participation. The study was approved by the
local Ethical Committee.
The study groups are represented diagram-
matically in Fig. 1. A total of 53 patients
fulﬁlling DSM-IV (APA, 1994) criteria for
schizophrenia (n=47), schizoaﬀective disorder
(n=5) or schizophreniform disorder (n=1) were
included in the study. Patients were divided into
two groups on the basis of family history: (a)
multiply aﬀected, where the proband had at
least one ﬁrst- or second-degree relative with
schizophrenia or other psychotic disorder, and
(b) ‘singly aﬀected’, where the proband had
no family history of schizophrenia or other
psychotic disorder as far as third-degree rela-
tives. Patients were recruited either in response
to advertisements through voluntary organiz-
ations or by direct referral from their treating
clinicians. Due to the comparative rarity of
multiply aﬀected families, these were speciﬁcally
targeted when advertising the study.
All available ﬁrst-degree relatives were
screened for mental health problems. Any who
were suspected of psychotic symptoms were
interviewed using the Schedule for Aﬀective
Disorders and Schizophrenia – Lifetime version
(SADS-L; Endicott & Spitzer, 1978), and were
reassigned to the Patient category if they
fulﬁlled diagnostic criteria for schizophrenia,
schizophreniform or schizoaﬀective disorder.
However, those with a lifetime history of a non-
psychotic DSM-IV disorder were not excluded.
The relatives from multiply aﬀected families
included 10 parents who were classiﬁed as ‘pre-
sumed obligate carriers ’, on the basis that (a)
they also had a sibling or parent aﬀected and (b)
transmission of liability was apparently uni-
lineal within that family.
Forty-one control subjects were recruited
from the local community via newspaper ad-
vertisements and from hospital and university
staﬀ. None of the control subjects had a per-
sonal or family history of schizophrenia or other
Total sample
(n =174)
Schizophrenia
(n =53)
Relatives
(n =80)
MA family
(n =25)
MA family
(n =31)
Obligate
carrier
(n =10)
Other
(n =21)
SA family
(n =28)
SA family
(n = 49)
Controls
(n = 41)
Non-schizophrenia
(n =121)
Contrast 1
Contrast 2
Contrast 3
Contrast 4
Contrast 5
FIG. 1. Composition of subject groups and contrasts. MA,
multiply aﬀected; SA, singly aﬀected.
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psychotic disorder. A lifetime personal or family
history of other psychiatric disorders was not an
exclusion criterion. Therefore, unlike many
previous studies, having a relative with schizo-
phrenia (or other psychotic disorder), was the
only criterion that distinguished between unaf-
fected relatives and controls. The diagnoses in
the six groups are shown in Table 1.
Clinical assessment
Patients, relatives, and controls were assessed
using the same clinical scales in face-to-face
interviews. Diagnoses were made using the
SADS-L and family history was assessed using
the Family Interview for Genetic Studies
(Nurnberger et al. 1994). Additional information
regarding the timing and nature of psychopath-
ology was collected for all participants allowing
DSM-IV diagnoses to be made. Clinical infor-
mation was always supplemented with collateral
histories with informants, and from medical
notes where available.
Eye-movement assessment
The antisaccade task was conducted using
the Amtech ET3 eye-tracking system (AmTech
GmbH, Weinheim, Germany). A Dell Optiplex
560/L computer (Dell Inc., Round Rock, TX,
USA) was used to control the apparatus, and
to record eye movements, using AmTech ET3
software. Eye movements were detected by
means of an infra-red reﬂection oculograph,
with eye position sampled at 200 Hz. The
stimuli consisted of a central LED, with per-
ipheral LEDs at 15x horizontally, mounted on
a board, 180 cm away from the subject’s eyes.
Eye-movement recordings were later analysed
using AmTech Eyemap version 2.0, by a trained
rater (H.S.) who was blind to diagnosis or sub-
ject group.
The tests were carried out as the last of
a battery of eye-movement tasks, including
smooth pursuit and prosaccade tasks. The sub-
jects were seated in a darkened room, and were
requested not to move their head, which rested
on an adjustable frame. At the start of each
trial, the central LED was illuminated. After
800 ms, the central LED was extinguished and
simultaneously, one of the peripheral targets
(¡15x eccentricity) was illuminated for 3 s
(accompanied by an audible signal) and then
returned to the centre. The subjects were
instructed to ﬁxate on the central target until it
moved to the peripheral position, and then to
direct their gaze as quickly and accurately as
possible to its mirror position (of equal distance
from, but in the opposite direction to, the
peripheral target). Blinks and other artefacts
were identiﬁed by inspection of the trace, and
removed from the analysis. A saccade was
deﬁned as a deﬂection of o2.5x. Any initial
saccade (discounting the ﬁrst 80 ms) towards
the peripheral target was scored as a distract-
ibility error. Where this was followed by a sac-
cade in the correct direction, the latter was
termed a corrective saccade. The number of
corrected distractibility errors divided by the
number of analysable trials gave the distract-
ibility error score. As well as the distractibility
error score, the mean latency of each type of
saccade (antisaccade, corrective saccade, and
distractibility error) was measured for each
subject.
Each participant completed a set of 12 prac-
tice trials to ensure that they understood the test
instructions. Subjects with an error rate of
Table 1. Lifetime DSM-IV diagnoses and demographic details in the six groups
Group
Schizo-
phrenia
Schizo-
phreniform
disorder
Schizo-
aﬀective
disorder MD
Other
DSM-IV
diagnosis
No
disorder
Age (yr) Education (yr)
Gender
(% males)Mean S.D. Mean S.D.
Sz, MA family 22 1 2 36.4 11.5 14.1 3.9 69.6
Sz, SA family 25 3 32.7 8.8 13.6 2.2 66.7
Obligate carrier 2 1 7 54.0 3.7 14.0 3.3 30.0
Relative, MA family 5 2 14 42.6 14.4 14.3 3.0 45.5
Relative, SA family 6 1 42 50.1 14.1 13.8 2.8 32.7
Control 4 37 41.9 14.7 13.7 3.5 41.5
F 9.9 0.2
x2 18.8
p <0.001 N.S. <0.01
MD, Major depression; Sz, schizophrenia ; MA, multiply aﬀected; SA, singly aﬀected.
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over 50% on the practice battery were given
a further explanation of the task, followed by a
second practice battery, with a maximum of
two practice batteries. Subjects then completed
two sets of 12 experimental trials, during which
the position of the stimulus was varied pseudo-
randomly throughout the set to prevent predic-
tive saccades, in the order LRRRLLRLLRRL.
Statistical analyses
Statistical analyses were conducted using SPSS
version 10.1 (SPSS Inc., Chicago, IL, USA) and
STATA version 7.0 (StataCorp., College Station,
TX, USA). Age and years of education were
compared between groups using analysis of vari-
ance (ANOVA), and gender using the x2 statistic.
Since members of a family are likely to
share both genes and environment, observations
from within the same family should not be
assumed to be independent, particularly for a
putative genetic marker. We therefore used
multilevel modelling to take account of the non-
independence of observations within families
using the ‘robust cluster ’ option in STATA. The
rationale for its use in studies of this type is
discussed more fully by Rabe-Hesketh et al.
(2001).
Age and gender were entered as covariates.
In order to allow the calculation of adjusted
means, we used a linear regression equation
without a constant, and centred the age variable
around the overall mean. Gender was coded
such that female was the reference category.
The regression coeﬃcients for the dummy
group variables therefore represented the group
means, adjusted to the mean age of the sample
and to female gender (Table 2).
We made comparisons between combinations
of groups in an orthogonal design, according
to the diagram in Fig. 1. The comparisons cor-
responded to our hypotheses, as stated above,
and were as follows: test 1, schizophrenia
patients versus all other groups; test 2, relatives
versus controls ; test 3, schizophrenia patients
from multiply aﬀected versus singly aﬀected
families ; test 4, relatives from multiply aﬀected
versus singly aﬀected families ; test 5, presumed
obligate carriers versus other relatives from
multiply aﬀected families.
The hypothesis that the performance of
patients would predict that of their relatives was
tested in our sample by dividing the patients
into ‘good’ and ‘poor’ groups, using a cut-oﬀ
score of the mean error score in controls+1 S.D.,
and then comparing the performance in the
relatives of each group using Student’s t test.
RESULTS
Demographic details
The demographic details of the groups are
shown in Table 1.
The schizophrenia patients had a mean length
of illness of 12.5 years (S.D.=10.6). The groups
were well matched for years of education, but
there were signiﬁcant group diﬀerences for age
[F=9.9 (5 d.f.), p<0.001] and gender [x2=18.77
(5 d.f.), p<0.01], and these variables were,
therefore, included in the regression equation.
Neither age (Pearson’s r=x0.13, p=N.S.)
nor gender (t=x0.337, p=N.S.) was associated
with saccadic distractibility score in the whole
sample, although saccadic distractibility was
signiﬁcantly correlated with length of illness
(r=0.37, p<0.01). However, some studies have
found that the relationship between age and
saccadic distractibility may be diﬀerent in
patients and controls (Crawford et al. 1998),
indicating that simply controlling for age across
the entire sample may not be appropriate. We
therefore tested for diﬀerent eﬀects of age in
diﬀerent groups by using group dummy vari-
ables to generate age x group interaction terms
and testing for diﬀerences between their re-
gression coeﬃcients. There were no signiﬁcant
diﬀerences (F=1.82, p=0.13). We are, there-
fore, satisﬁed that it was appropriate to control
for age over the whole sample.
Table 2. Raw and adjusted means for
saccadic distractibility by group
Group
Mean
saccadic
distractibility
(%) 95% CI S.D.
Mean
adjusted
for age
and gender
Sz, MA family 41.7 30.8–52.6 29.0 47.7
Sz, SA family 48.5 38.0–59.1 28.2 55.5
Obligate carrier 29.2 18.5–39.8 17.5 30.2
Relative, MA family 18.6 13.4–23.9 12.9 22.6
Relative, SA family 29.4 24.4–34.4 19.4 31.0
Control 26.6 20.5–32.6 19.4 30.7
Sz, Schizophrenia; MA, multiply aﬀected; SA, singly aﬀected.
95% conﬁdence intervals (CI) are shown. The means adjusted for
age and gender are the regression coeﬃcients for the dummy group
variables in the regression. They are based on the mean age of the
entire sample, and female gender.
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The raw and adjusted means for the six
groups are shown in Table 2.
The results of the Wald tests for orthogonal
comparisons between group means are shown
in Table 3. Hypothesis (1), that schizophrenia
patients would diﬀer from all other groups,
was supported. Hypotheses (2)–(5), which pre-
dicted diﬀerences between relatives and con-
trols, and between relatives and patients with
diﬀerent presumed genetic loading, were all
rejected.
Division of the schizophrenia patients in
to good and poor performers resulted in two
approximately equal groups of good (n=27)
and poor (n=26) performers. There was no
statistical diﬀerence in the error scores of rela-
tives of good performers (n=51, mean error
score=27.2) and relatives of poor performers
(n=29, mean error score=24.8, t=0.534,
p=0.595).
Other measures
Regression analyses similar to those described
above were conducted for other measures.
There were no signiﬁcant group diﬀerences for
latency of either correct or incorrect saccades, or
the proportion of antisaccade errors that were
corrected (Table 4).
DISCUSSION
As in all previous studies, schizophrenia patients
performed signiﬁcantly worse than relatives
and control subjects. However, we found no
evidence that such performance indicates a
genetic vulnerability to schizophrenia: unaﬀec-
ted relatives performed no worse than control
subjects, and there was no signiﬁcant diﬀerence
between members of singly or multiply aﬀected
families, nor between obligate carriers and other
relatives from multiply aﬀected families. While
these results do not preclude a genetic inﬂuence
on the antisaccade task, they do not support a
strong genetic overlap with schizophrenia.
Our results raise two important questions:
(a) Why are our results not in agreement with
some previous studies, which showed diﬀerences
between relatives and control subjects?
(b) If we are correct in concluding that sac-
cadic distractibility is not a genetic marker for
schizophrenia, then why is it elevated in schizo-
phrenia?
(a) Why are our results not in agreement with
previous studies?
Before answering the ﬁrst question, it should
be noted that few studies have conclusively
Table 3. Comparisons of group means for saccadic distractibility
Hypothesis Test group(s)
ADE
score Comparison group(s)
ADE
score F(1, 98) p
1 Schizophrenia 45.3 All others 26.6 32.3 <0.00001
2 All relatives 26.6 Controls 26.6 0.51 N.S.
3 Sz, MA families 41.7 Sz, SA families 48.5 1.03 N.S.
4 Relatives, MA families 22.0 Relatives, SA families 29.4 1.48 N.S.
5 Obligate carriers 29.2 Other relatives, MA families 18.6 1.43 N.S.
ADE, Antisaccade distractibility error; Sz, Schizophrenia; MA, multiply aﬀected; SA, singly aﬀected.
Table 4. Other measures : latencies
Schizophrenia,
MA families
Schizophrenia,
SA families
Obligate
carriers
Relatives, other
MA families
Relatives,
SA families Controls
Mean S.D. Mean S.D. Mean S.D. Mean S.D. Mean S.D. Mean S.D.
ADE latency
(ms)
305.0 54.0 298.4 35.4 311.2 58.3 277.9 85.8 316.8 52.4 302.2 83.7
Antisaccade
latency (ms)
417.2 171.0 394.8 133.3 418.2 65.4 406.7 55.7 445.2 79.6 400.0 84.6
ADEs
corrected (%)
87.2 24.6 93.1 17.0 100 — 90.3 30.1 96.8 14.6 95.2 16.7
MA, multiply aﬀected; SA, singly aﬀected. ADE, Antisaccade distractibility error.
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demonstrated diﬀerences in saccadic distract-
ibility between relatives and controls (Levy
et al. 2004). Many studies (Clementz et al.
1994; Thaker et al. 1996; Katsanis et al. 1997;
Crawford et al. 1998; Ross et al. 1998;
McDowell et al. 1999), have, however, shown
non-signiﬁcant trends for relatives to perform
more poorly than control subjects, whilst our
data showed an opposite trend.
Task parameters
Although the large diﬀerence in ADE score
between our patients and the rest of the sample
demonstrates that methodology of the study
was suﬃcient to detect highly signiﬁcant group
diﬀerences, the task parameters that we used
may not have been optimal for detecting diﬀer-
ences between groups. McDowell and others
have investigated the eﬀects of manipulations
of stimulus parameters on antisaccade per-
formance. In one study (McDowell et al. 1999),
patients and relatives could be better dis-
tinguished from controls using a 16x stimulus
eccentricity than 8x. At 15x, our study should,
therefore, be well placed to detect group diﬀer-
ences. The same group (McDowell & Clementz,
1997) have also investigated the eﬀect of intro-
ducing an overlap between the illumination of
the central cue and the peripheral target. They
found that a better separation between groups
was achieved in the ‘overlap’ condition than
in the standard version of the task. It is thus
possible that, had we used the overlap con-
dition, a diﬀerence would then have emerged
between relatives and controls. Our study used
24 trials per subject, whereas some have used
more (Thaker et al. 1996, 2000; McDowell &
Clementz, 1997; Karoumi et al. 2001). However,
the meta-analysis by Levy et al. (2004) demon-
strated that the number of trials did not inﬂu-
ence the eﬀect size.
Unlike most previous studies, we employed
an objective deﬁnition of a saccade, and used
a blinded rater. Both of these factors were
designed to eliminate observer bias.
Selection of relatives and controls
Saccadic distractibility has a poor speciﬁcity
for schizophrenia, with increased rates in uni-
polar depression (Sweeney et al. 1998), bipolar
aﬀective disorder (Sereno & Holzman, 1995;
Tien et al. 1996; Katsanis et al. 1997) and
obsessive–compulsive disorder (Tien et al. 1992;
Rosenberg et al. 1997). It follows that, if they
are to be comparable, relative and control
groups must be subject to the same exclusion
criteria with respect to psychiatric morbidity
and diﬀer only with regard to family history
of schizophrenia. However, in some studies,
controls were included only if they had a nega-
tive personal and family history of any psychi-
atric disorder, whereas this restriction was not
applied to relatives. In one study, for example
Katsanis et al. (1997), about one third of
‘well ’ relatives had a psychiatric disorder. These
relatives were compared to control subjects with
no lifetime history of any psychiatric disorder.
Since the lifetime population prevalence of psy-
chiatric disorders is estimated at over 1 in 4
(Goldberg, 1991) such ‘normal ’ controls are not
typical of the general population, and should
not be compared with relatives who have
signiﬁcant levels of morbidity. This issue has
recently been explored by Levy et al. (2004)
in a meta-analysis, which demonstrated that
whereas studies with asymmetrical exclusion
criteria tended to demonstrate large signiﬁcant
diﬀerences between relatives and controls, those
with symmetrical criteria showed smaller,
usually non-signiﬁcant, eﬀects.
In the present study, the only criterion that
distinguished the relative and control group
was the presence of psychosis in a ﬁrst-degree
relative.
The performance of our control sample
(26.6% error rate) is comparable to that of
previous studies (Brownstein et al. 2003). To
simulate the use of super-normal controls, we
excluded the four control subjects who had a
psychiatric history, but this did not change our
results. Nevertheless, our data did not allow us
to identify control subjects with a family history
of psychiatric disorders, so the eﬀects of this
could not be tested.
Statistical analysis
Our analysis diﬀered from most previous studies
in two main respects. First, we used robust
standard errors, taking into account non-
independence of observations from within the
same family. Second, we controlled for age and
gender. Previous studies have demonstrated an
increase in saccadic distractibility with normal
ageing (Sweeney et al. 2001), and Crawford
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et al. (1998) found that females performed worse
than males in a similar sample of schizophrenia
subjects, their healthy ﬁrst-degree relatives, and
normal controls.
Publication bias
The tendency of authors, journals and reviewers
to favour positive results has been well docu-
mented. Furthermore, with some notable excep-
tions (Brownstein et al. 2003), the published
studies that have failed to show statistically
signiﬁcant diﬀerences between relatives and
control subjects have not always made this
clear. We are aware of other negative ﬁndings
that have not been published (P. Clissa and
A. Jablensky, personal communication).
Lack of power
Our sample size was clearly adequate to dem-
onstrate highly signiﬁcant diﬀerences between
schizophrenia and non-schizophrenia subjects.
Although the contrast between schizophrenia
and non-schizophrenia subjects had somewhat
greater power than the contrast between un-
aﬀected relatives and controls, our data indicate
that if the ﬁrst-degree relatives of schizophrenia
patients do have a deﬁcit in saccadic distract-
ibility, it is very small compared to the deﬁcit
in patients.
(b) If saccadic distractibility is not a genetic
marker for schizophrenia, then why is it
elevated in schizophrenia?
Marker of environmental risk factors
A number of early and late environmental risk
factors for schizophrenia have been identiﬁed,
including pregnancy and birth complications,
winter birth and drug misuse (Murray &
Fearon, 1999). Saccadic distractibility could be
a marker for one or more of these risk factors.
Marker of the neuropathology of schizophrenia
Saccadic distractibility may be a marker of a
neuropathological process in schizophrenia.
Brain lesion and electrophysiological studies
of the antisaccade task have implicated a
large number of brain areas, particularly the
prefrontal cortex (Everling & Fischer, 1998).
Functional MRI studies suggest that prefrontal
activity is increased in normal, but not in
schizophrenia, subjects during antisaccade tasks
(McDowell et al. 2002). Furthermore, several
studies have found correlations between anti-
saccade distractibility error score and the
Wisconsin Card Sorting Test, an established test
of frontal lobe dysfunction (Milner & Petrides,
1996), in both normal and schizophrenic individ-
uals (Rosse et al. 1993; Crawford et al. 1995a, b,
1996; Tien et al. 1996; Radant et al. 1997;
Karoumi et al. 1998).
Direct eﬀect of antipsychotic drugs
Although abnormalities have been observed
in neuroleptic-naive schizophrenia patients
(Hutton et al. 1998), an eﬀect of medication
on antisaccade errors cannot be ruled out.
Crawford et al. (1995b) found that neuroleptic-
treated patients produced more saccadic dis-
tractibility errors than untreated patients.
Karoumi et al. (2001) noted a positive corre-
lation between antipsychotic dose (measured
in chlorpromazine dose equivalents) and dis-
tractibility error rate (Spearman’s rho=0.48,
p<0.05). In our sample, however, there was
no correlation between saccadic distractibility
and current antipsychotic dose, measured
in chlorpromazine equivalents (r=x0.153,
p=N.S.).
Chronic eﬀect of medication usage
Chronic eﬀects of antipsychotics would not
necessarily be detected by examining current
drug dose. Thaker et al. (1989) demonstrated a
two-fold excess of saccadic distractibility errors
in schizophrenia patients with tardive dyskine-
sia (TD), compared with those without TD. In
our own sample, saccadic distractibility was
signiﬁcantly correlated with length of illness
(r=0.37, p<0.01) but not with age (r=0.18,
p=N.S.) in schizophrenia subjects, a ﬁnding that
is compatible with an eﬀect of chronic medi-
cation or disease progression.
Marker of neurodegeneration or neuroplasticity
Although there is no conclusive evidence at
present of neurodegeneration in schizophrenia
(Allin & Murray, 2002), there have recently
been some suggestions of a progression of
brain abnormalities in schizophrenia, possibly
as a result of neuroplasticity (Weinberger &
McClure, 2002). Our ﬁnding of a correlation
between saccadic distractibility and length
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of illness is consistent with such an interpret-
ation.
Poor understanding of the task
The schizophrenia patients may have had a
worse comprehension of the task than other
groups, due, perhaps, to the presence of psy-
chotic symptoms. However, distractibility errors
were followed by a corrective saccade in around
90% of instances, with no signiﬁcant diﬀerence
between schizophrenia subjects and other groups
(see Table 4). Furthermore, we took steps to
minimize any such eﬀect by re-explaining the
task if the proportion of errors exceeded 50%
in the practice trial.
Part of a generalized neuropsychological deﬁcit
In a separate study using an overlapping sample,
we have found substantial correlations between
ADE score and both pre-morbid and current
IQ, verbal memory and associative learning,
most of which were not present in relatives
or control subjects (Zanelli et al. unpublished
observations). This suggests that, whatever the
cause of these antisaccade errors in schizo-
phrenia subjects, they are likely to represent part
of a more generalized deﬁcit.
Weaknesses of the study
As in most investigations of this type, the
patients in this study may have a higher level of
functioning than most schizophrenia subjects,
as they were all well enough to travel to the study
centre and participate willingly. Our groups
were not well matched for age and gender,
although we did not attempt to match them,
preferring to control for these statistically in
the analysis.
CONCLUSIONS
Schizophrenia patients perform poorly on the
antisaccade task, compared to their unaﬀected
relatives and controls, and the abnormality
appears to worsen with length of illness. How-
ever, our data do not provide support for the
hypotheses that the unaﬀected relatives of
patients have impaired performance, nor that
performance reﬂects genetic loading, either be-
tween or within families. These results challenge
the validity of saccadic distractibility as a puta-
tive genetic marker of schizophrenia.
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